EICHOR
● Recruiting
KSH01-TCRT Solid Tumors
Condition: TCR-T Cells · Refractory Solid Tumors · Relapsed Solid Tumors · Sponsor: TCRx Therapeutics Co.Ltd
About this study
1\) Safety and efficacy of TCR-T cells in subjects with refractory/relapsed solid tumors. 2) The activation and proliferation of TCR-T cells in the subject, and the survival time.
This description comes directly from the study's public registry record.
Talk to the study team
clinical trials ksh · 18994103369 · ksh-clinicalt@tcrximmune.com
Always discuss trial participation with your own doctor first.
Locations (1)
| The first affiliated hospital of Guang Xi medical university | Nanning, Guangxi, China | Recruiting |
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05539833